Beacon Topco, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
Beacon Topco, Inc. files its Q2 2026 10-Q, detailing its formation and preparations for a business combination with Barinthus Biotherapeutics plc and Clywedog Therapeutics, Inc.